Our Partnership
Our Partners
InCurA
InCurA is a KAUST-based company developing a pipeline of products based on its unique know-how and technologies that offer high-performance and enhanced efficacy, as well as low-cost manufacturing. InCurA’s strategic partners include KAUST and the Saudi NIH. InCurA’s lead products, ColiSorB and CurASeal (both covered by US patents), are manufactured via ROYAH PHARMA. ColiSorB and CurASeal are the first Saudi hemostatic agents to be fully innovated and manufactured in the KSA.
Frequently asked questions
InCurA is known for its exceptional ability to rapidly promote blood clotting, making it highly effective in emergency and medical situations where stopping bleeding quickly is crucial.
No, InCurA does not need pre-wetting. This unique feature allows for immediate application without the need for additional preparation, making it convenient and easy to use
InCurA has superior absorption capability pto 60x , allowing it to quickly absorb blood and other fluids. This enhances its effectiveness in controlling bleeding and maintaining a clean wound area.